A randomised, prospective, placebo-controlled phase III multicentre clinical trial (KyberSept) has been performed to test the efficacy of high-dose antithrombin therapy in patients with severe sepsis...
Keywords: heparin, antithrombin III, severe sepsis, bleeding, survival
05/2006 | Thrombosis and Haemostasis, Schattauer